S&P Could Snap 6-Day Win Streak
The S&P 500 slipped Tuesday, as investors digested strong gains from recent sessions.The Dow Jones Industrials tumbled 157.44 points to 42,634.63. The much-broader index fell back 80.61 points to 5,939.35The NASDAQ Composite lost 80.61 points to 19,134.86.Tech was the worst-performing S&P 500 sector, losing around 0.9%. Nvidia lost 2%. Meta Platforms, Apple and Microsoft were also lower on the day.Home Depot traded slightly higher after the home improvement retailer stuck by its full-year guidance, expecting total sales for the full year to grow by 2.8%. CFO Richard McPhail also said the company doesn’t have any plans to raise prices in the face of higher tariffs.The moves come a day after the S&P 500 eked out a small gain to stretch its winning streak to six days. That’s its longest run since a nine-day streak that ended earlier this month. While Monday’s gains were marginal, they did add to what has been a rapid and sharp rebound for stocks over the past five weeks. The S&P 500 is now about 3% from its record high.The 30-year Treasury yield was last three basis points higher at 4.971% after briefly surging past 5% on Monday.Treasury prices and yields move in opposite directions. Oil prices declined 42 cents to $62.27 U.S. a barrel. Prices for gold rallied $46.30 to $3,270.80
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


